Managers
The Kempen European Private Equity Fund has acquired a significant direct interest in Wilvo Group a family business in the province of Brabant in the Netherlands that specialises in the processing of thin sheet metal and precision parts assembly.
Wilvo Group employs 230 people and has an annual turnover of approximately EUR50 million.
The participation of the Kempen European Private Equity Fund is a co-investment with the German investment company Steadfast Capital. The investors have backed the management buy-out by the Wilvo management team, who, as new co-owners, are highly motivated to drive further growth for Wilvo Group, both
Private equity manager Keensight Capital has acquired Infarco’s majority stake in 3P Biopharmaceuticals, a Contract Development and Manufacturing Organisation (CDMO) specialised in the process development and GMP manufacturing of biologics.
Founded in 2006 and based near Pamplona, Spain, 3P Biopharmaceuticals offers a complete biologics production service, from preclinical and clinical stages, all the way to full-scale commercial manufacturing.
3P provides a comprehensive service which is focused on quality, flexibility and a strong, two-way partnership with its clients.
With more than 240 employees and a wide number of customers located in Europe, North America, Australia and Asia, 3P Biopharmaceuticals has successfully
CEE private equity firm Innova Capital is to acquire Optiplaza, one of the major players in the Romanian optical market. The transaction marks further stronger entry of the fund into the attractive and growing optical market.
The funds managed by Innova Capital have signed an agreement to acquire 100 per cent of shares in Optiplaza. This is the second transaction by Innova Capital in the optical space in Romania this year. Both transactions are currently being assessed by the Competition Council and will be implemented following their clearance by the competition authority.
Optiplaza was set up in 2004 and
DW Healthcare Partners, a private equity firm focused primarily on making control investments in North American middle market healthcare companies, has closed its fifth fund.
The fund was oversubscribed and met its cap of USD610 million in total capital commitments. This brings DW Healthcare Partners’ total capital under management to USD1.43 billion.
“We are grateful for the support we have received from both previous and new investors in Fund V. We believe we have earned their trust through our long track record, sourcing model, and differentiated investment strategy,” says DW Healthcare Partners’ Co-Founder and Managing Partner, Andrew Carragher.
DW Healthcare
Venture capital funds globally reached their best post-2009 crisis period performance in Q4 2018, surpassing the previous best recorded one year earlier, according to eFront’s latest Quarterly Private Equity Performance report.
Performance of VC funds globally reached 1.531x in Q4 2018 – the highest level on record – before dipping back below 1.5x in the first quarter of this year.
2018 was the best ever year for VC performance, with high returns associated with low risk and shorter time-to-liquidity, as VC funds capitalised on a favourable exit environment.
Return dispersion in 2019 remains below the level seen in 2014 to
By Elizabeth Pfeuti – Co-investments remain a theme in 2019, as both GPs and LPs increasingly see value in separate partnerships alongside commingled funds.
Earlier this year, the listed Standard Life Private Equity Trust announced it would allocate up to 20 per cent of its net asset value to these partnerships, kicking off with a stake in Midlands-based Mademoiselle Desserts alongside Europe-focused IK Investment Partners.
Institutional investors, too, such as pension and sovereign wealth funds, are getting in on the act. Some of the largest public pensions in the US, including the Teacher Retirement System of Texas, which announced this year
Cairngorm Capital Partners’ second fund, Cairngorm Capital LP II, has acquired Millbrook Healthcare Limited (Millbrook), together with its subsidiaries, Ultimate Healthcare Limited and Consolor Limited.
The transaction marks Cairngorm Capital’s entry into the assisted living sector, a long-held objective for the firm, which was facilitated by the appointment of Dr Amit Thaper as Investment Director in April 2017. Dr Thaper, who practiced as an orthopaedic surgeon with the NHS for several years, will use his knowledge and expertise to help Millbrook to respond proactively to the challenges presented by an ageing population and to enhance service users’ experiences.
Established in
Foresight Group (Foresight) has invested a further GBP4 million of growth capital into portfolio company ONFAB to fund the acquisition of Lancashire based designer and manufacturer of clean air containment products, Envair Holdings Limited (Envair).
ONFAB produces flexible clean-air enclosures and consumables, designed and manufactured in-house from sites in Cheshire and Spain. Founded in 2005 by Oliver Nulty, ONFAB received investment from the GBP60 million Foresight Regional Investment LP fund in September 2017 to facilitate a majority buyout of the business. Since then, with an enlarged team and renewed focus on sales, margins and new products, it has grown by
VR hardware specialist Moiin is forming a USD100 million VC fund, based in Silicon Valley, to aid in the growth of VR gaming globally.
The team behind the new fund plans to seek investment opportunities globally to drive global VR development forward to help usher in the 4th Industrial Revolution of a fully immersive VR world.
Global investment bank GCA Altium has advised Cawood Scientific, a UK-based provider of accredited analytical testing and sampling services in the agriculture and environmental renewables sectors, on its partnership with Waterland Private Equity.
This is the second time that GCA Altium has advised Cawood, having supported the business on its secondary buyout by Inflexion Private Equity in 2017.
Cawood offers multi-disciplinary analytical sampling and testing services to the agronomy, livestock, agrochemical and environmental renewables sectors, and currently serves over 3,000 customers. Headquartered in Berkshire, the company operates across five accredited laboratories and an accredited sampling business, and is supported
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
